跳至主要内容
临床试验/NCT05447364
NCT05447364已完成4 期

Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty - A Randomized Controlled Trial

Thammasat University1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2021年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
82
试验地点
1
主要终点
Difference on 100-mm Visual analog scale (VAS) Pain Score between 75 mg of Pregabalin and 150 mg of Pregabalin groups

研究概览

简要总结

The purpose of this study is to compare the efficacy of 75 mg of Pregabalin and 150 mg of Pregabalin in postoperative pain control after TKA.

详细描述

After being informed about the study and potential risks, all patients giving written informed consent will be chosen for eligibility for the study entry. At the day before surgery date, patients who meet the eligibility criteria will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to 75 mg of Pregabalin and 150 mg of Pregabalin groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
55 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic primary knee osteoarthritis undergoing unilateral TKA
  • Aged between 55 and 80 years old
  • Comply with protocol

排除标准

  • Allergy to any of the medications in this protocol (Pregabalin, Morphine, Paracetamol, Celecoxib, Tramadol, Aspirin)
  • Secondary osteoarthritis of the knee including autoimmune diseases and post-traumatic
  • Previous surgery on the knee
  • Contraindicated to spinal anesthesia (SB) or Adductor canal block (ACB)
  • GFR < 30ml/min, Severe Liver Function (Child-Pugh C)
  • History of seizure or cerebrovascular diseases

研究组 & 干预措施

75 mg of Pregabalin

Experimental

Participant received 1 tab of 75 mg of Pregabalin and 1 tab of placebo

干预措施: Pregabalin 75mg (Drug)

150 mg of Pregabalin

Active Comparator

Participant received 2 tabs of 75 mg of Pregabalin

干预措施: Pregabalin 150mg (Drug)

结局指标

主要结局

Difference on 100-mm Visual analog scale (VAS) Pain Score between 75 mg of Pregabalin and 150 mg of Pregabalin groups

时间窗: 6, 12, 18, 24, 48 hours & 2, 6, 12 weeks after surgery

* The 100-mm VAS pain score is a self-reported instrument assessing pain scores. * Participants will assess the VAS pain score at rest and on-movement * VAS Pain at rest is evaluated when the participant is at rest. * VAS Pain on-movement is evaluated on active extension and flexion of the operated knee using mean scores between the two. * Possible scores range from 0 (no pain) to 100 (worst imaginable pain) * Higher scores mean a worse pain

次要结局

  • Difference on side effects between 75 mg of Pregabalin and 150 mg of Pregabalin groups(6, 12, 18, 24, 48 hours & 2, 6, 12 weeks after surgery)
  • Difference on Range of motion between 75 mg of Pregabalin and 150 mg of Pregabalin groups(2, 6, 12 weeks after surgery)
  • Difference on time to ambulation between 75 mg of Pregabalin and 150 mg of Pregabalin groups(From postoperative period until 48 hours after surgery)
  • Difference on Time up-and-go test between between 75 mg of Pregabalin and 150 mg of Pregabalin groups(2, 6, 12 weeks after surgery)
  • Difference on 2-minutes walking test between 75 mg of Pregabalin and 150 mg of Pregabalin groups(2, 6, 12 weeks after surgery)
  • Difference on length of stay between 75 mg of Pregabalin and 150 mg of Pregabalin groups(From postoperative period until 48 hours after surgery)
  • Difference on Morphine consumption between 75 mg of Pregabalin and 150 mg of Pregabalin groups(From postoperative period until 48 hours after surgery)
  • Difference on Knee Society Score between 75 mg of Pregabalin and 150 mg of Pregabalin groups(2, 6, 12 weeks after surgery)
  • Difference on Knee injury and Osteoarthritis Outcome Score between 75 mg of Pregabalin and 150 mg of Pregabalin groups(2, 6, 12 weeks after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seksan Kukreja

Principal Investigator

Thammasat University

研究点 (1)

Loading locations...

相似试验